BNP Paribas Financial Markets’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,097	Closed	-$32.4K	–	3465
2015 Q4	$32.4K	Buy	1,097 +80	+8%	+$2.42K	﹤0.01%	3082
2015 Q3	$32.1K	Buy	1,017 +655	+181%	+$31.3K	﹤0.01%	3139
2015 Q2	$21.4K	Buy	362 +284	+364%	+$20K	﹤0.01%	2998
2015 Q1	$8.35K	Buy	+78	New	+$7.43K	﹤0.01%	2852
2014 Q4	–	Sell	-280	Closed	-$21.5K	–	3867
2014 Q3	$21.5K	Buy	280 +252	+900%	+$19.8K	﹤0.01%	3122
2014 Q2	$2.51K	Buy	28 +23	+460%	+$1.41K	﹤0.01%	2969
2014 Q1	$231	Sell	5 -18	-78%	-$594	﹤0.01%	3187
2013 Q4	$570	Buy	+23	New	+$548	﹤0.01%	3922

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BNP Paribas Financial Markets's PTX Position: Q1 2016 in Review

BNP Paribas Financial Markets sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2016, closing a stake of 1,097 shares — an estimated $32.4K sold.

BNP Paribas Financial Markets first reported a position in PTX in Q4 2013 and held it in 8 quarters. The position peaked at $32.4K in Q4 2015. 88 funds tracked by Wall St. Rank hold PTX as of Q1 2016.

BNP Paribas Financial Markets reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2016 after selling out during the quarter.
BNP Paribas Financial Markets sold 1,097 Pernix Therapeutics Holdings, Inc. shares in Q1 2016, an estimated $32.4K.
BNP Paribas Financial Markets first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2013 and held it in 8 quarters.
BNP Paribas Financial Markets's Pernix Therapeutics Holdings, Inc. position peaked at $32.4K in Q4 2015.
88 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2016, filed 22 Apr 2016.